Bisoendial RJ - Search Results

1

C-reactive protein is a mediator of cardiovascular disease.

Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ. Bisoendial RJ, et al. Eur Heart J. 2010 Sep;31(17):2087-91. doi: 10.1093/eurheartj/ehq238. Epub 2010 Aug 3. Eur Heart J. 2010. PMID: 20685682 Review.

2

Activation of inflammation and coagulation after infusion of C-reactive protein in humans.

Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den Bogaard B, Reitsma PH, Meijers JC, Hartman D, Levi M, Stroes ES. Bisoendial RJ, et al. Circ Res. 2005 Apr 15;96(7):714-6. doi: 10.1161/01.RES.0000163015.67711.AB. Epub 2005 Mar 17. Circ Res. 2005. PMID: 15774855

3

C-reactive protein and atherogenesis: from fatty streak to clinical event.

Bisoendial RJ, Kastelein JJ, Stroes ES. Bisoendial RJ, et al. Atherosclerosis. 2007 Dec;195(2):e10-8. doi: 10.1016/j.atherosclerosis.2007.04.053. Epub 2007 Jul 31. Atherosclerosis. 2007. PMID: 17669411 Review.

4

Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins.

Bisoendial RJ, Stroes ES, Kastelein JJ, Tak PP. Bisoendial RJ, et al. Nat Rev Rheumatol. 2010 Mar;6(3):157-64. doi: 10.1038/nrrheum.2009.277. Epub 2010 Feb 9. Nat Rev Rheumatol. 2010. PMID: 20142814 Review.

5

ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans.

van Leuven SI, Birjmohun RS, Franssen R, Bisoendial RJ, de Kort H, Levels JH, Basser RL, Meijers JC, Kuivenhoven JA, Kastelein JJ, Stroes ES. van Leuven SI, et al. Among authors: bisoendial rj. J Thromb Haemost. 2009 Feb;7(2):347-54. doi: 10.1111/j.1538-7836.2008.03175.x. Epub 2008 Oct 1. J Thromb Haemost. 2009. PMID: 18983488 Free article.

6

Critical determinants of cardiovascular risk in rheumatoid arthritis.

Bisoendial RJ, Stroes ES, Tak PP. Bisoendial RJ, et al. Curr Pharm Des. 2011;17(1):21-6. doi: 10.2174/138161211795049741. Curr Pharm Des. 2011. PMID: 21226666 Review.

7

Measurement of subclinical atherosclerosis: beyond risk factor assessment.

Bisoendial RJ, Hovingh GK, de Groot E, Kastelein JJ, Lansberg PJ, Stroes ES. Bisoendial RJ, et al. Curr Opin Lipidol. 2002 Dec;13(6):595-603. doi: 10.1097/00041433-200212000-00002. Curr Opin Lipidol. 2002. PMID: 12441883 Review.

8

A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.

Hovingh GK, Brownlie A, Bisoendial RJ, Dube MP, Levels JH, Petersen W, Dullaart RP, Stroes ES, Zwinderman AH, de Groot E, Hayden MR, Kuivenhoven JA, Kastelein JJ. Hovingh GK, et al. Among authors: bisoendial rj. J Am Coll Cardiol. 2004 Oct 6;44(7):1429-35. doi: 10.1016/j.jacc.2004.06.070. J Am Coll Cardiol. 2004. PMID: 15464323 Free article.

9

Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects.

Bisoendial RJ, Kastelein JJ, Peters SL, Levels JH, Birjmohun R, Rotmans JI, Hartman D, Meijers JC, Levi M, Stroes ES. Bisoendial RJ, et al. J Lipid Res. 2007 Apr;48(4):952-60. doi: 10.1194/jlr.P600014-JLR200. Epub 2007 Jan 26. J Lipid Res. 2007. PMID: 17259597 Free article.

10

A single bolus infusion of C-reactive protein increases gluconeogenesis and plasma glucose concentration in humans.

Birjmohun RS, Bisoendial RJ, van Leuven SI, Ackermans M, Zwinderman A, Kastelein JJ, Stroes ES, Sauerwein HP. Birjmohun RS, et al. Among authors: bisoendial rj. Metabolism. 2007 Nov;56(11):1576-82. doi: 10.1016/j.metabol.2007.06.026. Metabolism. 2007. PMID: 17950110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters